Oragenics Announces Positive Data on Intranasal COVID-19 Vaccine Candidate
American biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreRead the latest pharmaceutical industry press releases, news updates and articles on coronavirus COVID-19 medical treatment, therapies and drug and vaccine development.
American biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreThe U.S. Food and Drug Administration (FDA) has approved a second COVID-19 vaccine developed by Moderna, which will be marketed
Read morePfizer and BioNTech announced on Tuesday that a clinical trial in healthy people 18 to 55 years old to assess
Read moreEvotec, a publicly listed drug discovery and development company, has won a € 7.5 million grant for the development of
Read morePfizer’s COVID-19 Antiviral, PAXLOVID, has been authorised for use in people over 18 with mild to moderate COVID-19 and at
Read moreThe award-winning Ireland-based medical device company Aerogen and the innovative Chinese vaccine company CanSinoBIO entered into a partnership earlier this
Read moreVaccine maker Moderna, which is at the forefront of developing messenger RNA (mRNA) therapeutics and vaccines, announced today that according
Read moreEvusheld, a long-acting antibody (LAAB) combination from AstraZeneca, has received emergency use authorisation (EUA) by the FDA in the United
Read morePreliminary laboratory studies have shown that three doses of the Pfizer-BioNTech COVID-19 Vaccine can neutralize the Omicron variant (B.1.1.529 lineage),
Read moreLeading vaccine producers have stated that new vaccines will be developed if necessary to meet the demand of governments worldwide
Read more